Related by context. Frequent words. (Click for all words.) 59 genetic determinants 59 cognitive domains 58 molecular biomarkers 57 genetic polymorphisms 56 pharmacokinetic parameters 56 cellular pathways 56 pharmacokinetic profiles 56 cytotoxic agents 56 microRNA expression 56 prognostic factors 55 Nanobodies 55 therapeutic regimens 55 dose regimens 55 metabolic parameters 55 Neuradiab 55 diagnostic biomarkers 55 univariate 55 GFT# 55 T2DM 55 subpopulations 54 liposomal formulation 54 Recurrence Score 54 analgesic efficacy 54 methylation patterns 54 K RAS 54 gene expression profiles 54 dosing regimens 54 pharmacodynamic effects 54 lipid abnormalities 54 subgroup analyzes 54 anti fibrotic 53 platelet reactivity 53 nonrandomized 53 pharmacokinetics PK 53 secondary efficacy endpoints 53 morphologic 53 neuroimaging studies 53 cardiometabolic risk 53 efficacy tolerability 53 platelet function 53 xenograft models 53 EGFR mutations 53 CCX# 53 prognostic significance 53 Observational studies 53 hsCRP 53 clinically validated 53 efficacy endpoint 52 mRNA expression 52 neuroprotective properties 52 poor metabolizers 52 histone modifications 52 pharmacogenetic 52 anticancer therapies 52 antihypertensive therapy 52 radiographically 52 immunohistochemical 52 qRT PCR 52 gene expression patterns 52 warfarin dose 52 pharmacodynamic 52 therapeutically relevant 52 carcinoid 52 sporadic ALS 52 prognostic marker 52 serum concentrations 52 physiological parameters 52 covariate 51 tecarfarin 51 subtypes 51 platelet inhibition 51 histopathologic 51 metabolic abnormalities 51 QTinno 51 dosing schedules 51 atherothrombosis 51 lipid lowering therapy 51 epitopes 51 multivariate analyzes 51 PLX cells 51 genotypic 51 RRMS patients 51 therapeutic modalities 51 pharmacokinetic properties 51 ischemic cardiomyopathy 51 KRAS mutations 51 chromosomal regions 51 quantitative PCR 51 placebo controlled clinical trials 51 biochemical markers 51 estrogen receptor ER 51 histopathological 51 stenoses 51 chronicity 50 liver transplant recipients 50 nomogram 50 superficial bladder cancer 50 T2D 50 pharmacokinetic PK 50 phenotyping 50 antihypertensive agents